# Corvus Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed May 1, 2025

- Company: [Corvus Pharmaceuticals, Inc.](/companies/crvs.md) (CIK 1626971)
- Form: SCHEDULE 13D/A
- Filed: 2025-05-01
- Accepted by EDGAR: May 1, 2025, 21:20 ET
- Period: not reported
- Accession: 0000947871-25-000444
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1626971/000094787125000444/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1626971/000094787125000444/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1626971/000094787125000444/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 1, 2025.
Source: SEC EDGAR, the filing index for accession 0000947871-25-000444. Last ingested by Listed: Nov 15, 2026, 00:49 ET. No prices; not investment advice.
